Search for: "C Lillie"
Results 321 - 340
of 444
Sort by Relevance
|
Sort by Date
19 Apr 2011, 5:15 pm
Click here for a link to a C-Span BookTV interview of Bass.The WSJ reviewed the book: "Prozac improved the nation's mood when it came on the market in 1987. [read post]
15 Apr 2011, 6:02 am
Eli Lilly & Co., 2011 WL 1259650 (W.D. [read post]
6 Apr 2011, 12:18 am
(KEI) (Patently-O) (The Prior Art) (Patent Law Practice Center) (EFF) (Patent Docs) US farmers sue Monsanto over GMO patents, demand right to conventional crops (IP Watch) (IP Biz) US: BIO commends launch of House patent reform process: Expresses concern with inter partes review changes (PatentlyBIOtech) US: Oncolytics files for correction of PTA calculation for ‘Reoviruses having modified sequences’ patent (Patent Docs) Products Akatinol (Memantine) – EU: AG offers alternative… [read post]
1 Apr 2011, 7:30 am
Eli Lilly & Co., 65 Va. [read post]
28 Mar 2011, 10:51 am
§ 3730(c)(4). [read post]
23 Feb 2011, 10:58 am
Ltd., No. 08 C 0953, 2009 U.S. [read post]
10 Feb 2011, 5:35 pm
(CC) The patent information submitted under [FDC Act § 505(b) or (c)] is withdrawn by the holder of the application approved under subsection (b). [read post]
3 Feb 2011, 2:11 pm
A few weeks ago a regular reader, and occasional correspondent, Prof. [read post]
31 Jan 2011, 8:10 am
Eli Lilly, just to name a few. [read post]
31 Jan 2011, 8:10 am
Eli Lilly, just to name a few. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
24 Jan 2011, 4:55 am
Finally Matt addressed industrial applicability, there being a new case to cite in Eli Lilly v Human Genome Sciences Inc, as well as a string of perpetual motion machines. [read post]
20 Jan 2011, 4:50 pm
Cir. 2006) ("[C]laim differentiation takes on relevance in the context of a claim construction that would render additional, or different, language in another independent claim superfluous . . . . [read post]
27 Dec 2010, 9:10 pm
Lilly’s undisputed testimony established that Crawley told Lilly he could search the “inside” of the car before Lilly issued the summonses to Allen. [read post]
20 Nov 2010, 6:11 pm
It was claimed that Propoxyphene had no or little contribution to efficacy of reduction of acute pain.Darvon was initially developed by Eli-Lilly and now marketed by two companies--Xanodyne Pharmaceuticals of Kentucky and Qualitest/Vintage Pharmaceuticals of Alabama--was first approved for use in the United States in 1957. [read post]
9 Nov 2010, 4:30 am
., 04-C-3967, 27th Judicial Court, St. [read post]
10 Oct 2010, 6:21 am
Also brought within the IPO’s corral is the decision in Dr Reddy’s Laboratories (UK) Ltd v Eli Lilly & Co Ltd [2010] RPC 8 (noted by the IPKat here), in which the Court of Appeal delved into the murky depths of selection invention – asking, in the process, where a wise man would hide a leaf… The sections on supplementary protection certificates has also been updated in light of the decisions of the High Court in Yeda Research and Development Company Ltd v… [read post]
30 Sep 2010, 2:29 pm
We like the stronger interpretation of Fed. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen, ‘yes’ to Member… [read post]
31 Aug 2010, 10:01 pm
(FDA Law Blog) US: District Court N D Illinois construes claims re method of treating kidney disease: Bone Care v Pentech Pharma (Chicago IP Litigation Blog) Products Angiomax (Bivalirudin) – US: Medicines Company files patent infringement complaint against Hospira in response to Para IV challenge (Patent Docs) Aranesp (Darbepoetin) – EU: ECJ to rule on Aranesp Thursday 2 Sept: Case C-66/09 Kirin Amgen (The SPC Blog) Baraclude (Entecavir) – India: Natco and Zydus Cadila… [read post]
